Abstract (from the Book of Abstracts).
At the present time, it is estimated that 40% of the world’s population
is exposed to the risk of contracting malaria, and that every year about
2.7 million people die in consequence of that disease. The appearance of
resistant strains of Plasmodium falciparum to some of drugs in common clinical
usage has made necessary further investigation of new classes of compounds
as artemisinin and its derivatives. The mechanism of artemisinin antimalarial
activity includes heme-catalyzed artemisinin activation into a very reactive
radical, which then could covalently bind to parasite proteins, heme, hemozoin,
reduced glutathione or other parasite molecule. QSAR study [1] on 17 antimalarial
C9, C10-substituted artemisinins against Plasmodium falciparum (biological
activities from literature [2, 3]) was performed by means of quantum chemical
(ab initio HF/6-31G* level), chemometric (Principal Component and
Hierarchical Cluster Analyses, Partial Least Squares Regression) and molecular
graphics and modeling methods. Prediction of antimalarial activities for
10 proposed C9, C10-substituted artemisinins was performed. Docking of
some artemisinins to heme and hemoglobin, as well as structural studies
on heme-receptor complexes, was carried out also. The PLS model with four
latent variables explaining 91.61% of logIC50 variance (Q2 = 0.95 and R2
= 0.96) was obtained. Molecular descriptors were LUMO+1 energy, atomic
charges in C9 and C10, the maximum number of hydrogen atoms that might
make contacts with heme, and a WHIM-3D index related to molecular symmetry.
Two from ten proposed artemisinin derivatives were predicted with antimalarial
activities higher than the compounds reported in literature. The docking
confirmed the PLS results and gave more insight into the nature of heme-artemisinin
and hemoglobin-artemisinin interactions, and made it possible to explain
why some artemisinins can be highly active.
[1] Pinheiro J. C., Ferreira M. M. C., Kiralj R., Reis
R. M, Romero O. A. S. Submitted for
publication
[2] Acton N., Karle J. M., Miller R. E. J. Med. Chem.
1993; 36: 2552-7.
[3] Acton N., Klayman D. L. Planta Med. 1987; 53: 266-8.
Keywords.
Keywords Plus.